# Inrebic

NDC: 59572-720
Generic name: Fedratinib Hydrochloride
Labeler / Manufacturer: Celgene Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20190816

FDA application: NDA212327

## Active ingredients

- FEDRATINIB HYDROCHLORIDE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59572-720"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59572-720
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f0f55a2a-4e0c-4cba-8571-03e1424486d7